Nikko Asset Management Americas’s Arcturus Therapeutics ARCT Stock Holding History

Nikko Asset Management Americas’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17.6M	Buy	2,288,935 +262,347	+13%	+$1.91M	0.25%	67
2025 Q4	$12.4M	Buy	2,026,588 +78,753	+4%	+$851K	0.14%	86
2025 Q3	$35.9M	Buy	1,947,835 +117,632	+6%	+$1.89M	0.35%	63
2025 Q2	$23.8M	Sell	1,830,203 -95,881	-5%	-$1.13M	0.24%	71
2025 Q1	$20.4M	Sell	1,926,084 -138,966	-7%	-$2.21M	0.26%	64
2024 Q4	$34.9M	Sell	2,065,050 -250,244	-11%	-$4.71M	0.38%	52
2024 Q3	$53.7M	Buy	2,315,294 +752,229	+48%	+$16.1M	0.61%	42
2024 Q2	$38M	Buy	1,563,065 +286,546	+22%	+$8.69M	0.44%	48
2024 Q1	$43M	Sell	1,276,519 -44,133	-3%	-$1.56M	0.43%	52
2023 Q4	$41.6M	Sell	1,320,652 -67,922	-5%	-$1.61M	0.4%	50
2023 Q3	$35.4M	Sell	1,388,574 -16,358	-1%	-$504K	0.42%	51
2023 Q2	$40.3M	Sell	1,404,932 -15,469	-1%	-$421K	0.42%	50
2023 Q1	$33M	Sell	1,420,401 -28,659	-2%	-$514K	0.38%	44
2022 Q4	$24.6M	Sell	1,449,060 -10,355	-0.7%	-$181K	0.35%	51
2022 Q3	$21.2M	Buy	1,459,415 +23,221	+2%	+$390K	0.27%	64
2022 Q2	$18M	Buy	1,436,194 +34,116	+2%	+$669K	0.22%	67
2022 Q1	$37.9M	Buy	1,402,078 +44,606	+3%	+$1.14M	0.28%	67
2021 Q4	$47.8M	Sell	1,357,472 -1,060	-0.1%	-$43.2K	0.25%	71
2021 Q3	$62.5M	Buy	1,358,532 +143,631	+12%	+$6.44M	0.27%	70
2021 Q2	$41.2M	Buy	1,214,901 +899,089	+285%	+$30.4M	0.16%	82
2021 Q1	$13M	Buy	315,812 +38,126	+14%	+$2.27M	0.06%	124
2020 Q4	$12M	Buy	277,686 +146,516	+112%	+$9.92M	0.07%	123
2020 Q3	$5.63M	Sell	131,170 -12,317	-9%	-$611K	0.05%	133
2020 Q2	$6.56M	Sell	143,487 -111,579	-44%	-$3.85M	0.09%	98
2020 Q1	$3.47M	Sell	255,066 -25,482	-9%	-$326K	0.06%	113
2019 Q4	$3.05M	Sell	280,548 -17,982	-6%	-$188K	0.05%	141
2019 Q3	$3.07M	Buy	298,530 +168,556	+130%	+$1.82M	0.05%	139
2019 Q2	$1.23M	Buy	129,974 +65,875	+103%	+$483K	0.02%	154
2019 Q1	$438K	Buy	+64,099	New	+$328K	0.01%	156